Sivik Global Healthcare’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-22,500
| Closed | -$2.11M | – | 49 |
|
|
2022
Q1 | $2.11M | Buy |
+22,500
| New | +$2.11M | 0.87% | 46 |
|
|
2019
Q3 | – | Sell |
-40,000
| Closed | -$3.38M | – | 53 |
|
|
2019
Q2 | $3.38M | Buy |
+40,000
| New | +$3.38M | 0.82% | 34 |
|
|
2018
Q2 | – | Sell |
-30,000
| Closed | -$2.49M | – | 70 |
|
|
2018
Q1 | $2.49M | Sell |
30,000
-5,000
| -14% | -$415K | 1.16% | 35 |
|
|
2017
Q4 | $2.72M | Buy |
35,000
+5,000
| +17% | +$388K | 1.01% | 48 |
|
|
2017
Q3 | $1.84M | Buy |
30,000
+10,000
| +50% | +$613K | 0.63% | 59 |
|
|
2017
Q2 | $920K | Sell |
20,000
-5,000
| -20% | -$230K | 0.34% | 64 |
|
|
2017
Q1 | $1.08M | Hold |
25,000
| – | – | 0.5% | 56 |
|
|
2016
Q4 | $968K | Buy |
25,000
+9,400
| +60% | +$364K | 0.46% | 49 |
|
|
2016
Q3 | $790K | Buy |
+15,600
| New | +$790K | 0.4% | 46 |
|